CIPLA LTD vs KOVAI MEDICAL CENTER & HO

A side-by-side comparison of CIPLA LTD (CIPLA) and KOVAI MEDICAL CENTER & HO (KOVAI) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, KOVAI MEDICAL CENTER & HO leads CIPLA vs KOVAI on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

29.51
P/E ratio
27.01
3.42
P/B ratio
5.00
0.92%
Dividend yield
0.25%
₹48.02
EPS
₹223.41

Profitability

KOVAI takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

11.60%
Return on equity
18.50%
15.00%
Return on capital
22.00%
21.00%
EBITDA margin
27.68%
13.71%
Net margin
15.42%

Growth

KOVAI takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

7.37%
Revenue CAGR (3Y)
15.84%
10.88%
Profit CAGR (3Y)
28.21%

Size & financial health

CIPLA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.15L Cr
Market cap
₹6,606 Cr
₹28,163 Cr
Revenue
₹1,586 Cr
₹3,862 Cr
Net profit
₹244 Cr
0.00
Debt / equity
0.31
CIPLA LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 25.7%"]
  • ["The company has delivered a poor sales growth of 8.01% over past five years.", "Promoter holding has decreased over last 3 years: -4.24%"]
KOVAI MEDICAL CENTER & HO
  • + ["Company has delivered good profit growth of 26.0% CAGR over last 5 years"]
  • ["Company might be capitalizing the interest cost"]
CIPLA LTD full analysis KOVAI MEDICAL CENTER & HO full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.